Safety - OPEN Foundation

First study of safety and tolerability of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participants

Sessa, B., Sakal, C., O’Brien, S., & Nutt, D. | BMJ Case Reports CP | 15 July 2019

Acute subjective and behavioral effects of microdoses of LSD in healthy human volunteers

Bershad, A. K., Schepers, S. T., Bremmer, M. P., Lee, R., & de Wit, H. | Biological Psychiatry | 3 June 2019

Psychedelic-assisted therapies: The past, and the need to move forward responsibly.

Gardner, J., Carter, A., O’Brien, K., & Seear, K. | International Journal of Drug Policy | 25 May 2019

Dimethyltryptamine: Endogenous Role and Therapeutic Potential.

Rodrigues, A. V., Almeida, F. J., & Vieira-Coelho, M. A. | Journal of psychoactive drugs | 25 April 2019

A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms

Uthaug, M. V., Lancelotta, R., van Oorsouw, K., Kuypers, K. P. C., Mason, N., Rak, J., ... & Páleníček, T. | Psychopharmacology | 13 April 2019

Effects of the Psychedelic Amphetamine MDA (3,4-Methylenedioxyamphetamine) in Healthy Volunteers.

Baggott, M. J., Garrison, K. J., Coyle, J. R., Galloway, G. P., Barnes, A. J., Huestis, M. A., & Mendelson, J. E. | Journal of psychoactive drugs | 9 April 2019

Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration.

Fadiman, J., & Korb, S. | Journal of psychoactive drugs | 29 March 2019

A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy.

Sessa, B., Higbed, L., & Nutt, D. | Frontiers in Psychiatry | 20 March 2019

Chronic, Intermittent Microdoses of the Psychedelic N, N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents.

Cameron, L. P., Benson, C. J., DeFelice, B. C., Fiehn, O., & Olson, D. E. | ACS chemical neuroscience | 4 March 2019

Greater empathy in MDMA users

Carlyle, M., Stevens, T., Fawaz, L., Marsh, B., Kosmider, S., & Morgan, C. J. | Journal of Psychopharmacology | 5 February 2019

How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review.

Hoch, E., Niemann, D., von Keller, R., Schneider, M., Friemel, C. M., Preuss, U. W., ... & Pogarell, O. | European archives of psychiatry and clinical neuroscience | 31 January 2019

Microdosing psychedelics: personality, mental health, and creativity differences in microdosers.

Anderson, T., Petranker, R., Rosenbaum, D., Weissman, C. R., Dinh-Williams, L. A., Hui, K., ... & Farb, N. A. | Psychopharmacology | 2 January 2019

Effect of Ritualistic Consumption of Ayahuasca on Hepatic Function in Chronic Users.

Mello, S. M., Soubhia, P. C., Silveira, G., Corrêa-Neto, N. F., Lanaro, R., Costa, J. L., & Linardi, A. | Journal of psychoactive drugs | 22 December 2018

DARK Classics in Chemical Neuroscience: Atropine, Scopolamine, and Other Anticholinergic Deliriant Hallucinogens

Lakstygal, A., Kolesnikova, T., Khatsko, S., Zabegalov, K., Volgin, A., Demin, K., & Kalueff, A. | ACS chemical neuroscience | 19 December 2018

Classic Psychedelics: An integrative review of epidemiology, mystical experience, brain network function, and therapeutics

Johnson, M. W., Hendricks, P. S., Barrett, F. S., & Griffiths, R. R. | Pharmacology & therapeutics | 4 December 2018

Methylenedioxymethamphetamine (MDMA) in Psychiatry: Pros, Cons, and Suggestions.

Schenk, S., & Newcombe, D. | Journal of clinical psychopharmacology | December 2018

Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions

Garcia-Romeu, A., & Richards, W. A. | International Review of Psychiatry | 13 November 2018

Research ethics aspects of experimentation with LSD on human subjects: a historical and ethical review.

Bodnár, K. J., & Kakuk, P. | Medicine, Health Care and Philosophy | 16 October 2018

Ibogaine as a treatment for substance misuse: Potential benefits and practical dangers.

Corkery, J. M. | Progress in brain research | 12 October 2018

Understanding Central Nervous System Effects of Deliriant Hallucinogenic Drugs through Experimental Animal Models

Volgin, A. D., Yakovlev, O. A., Demin, K. A., Alekseeva, P. A., Kyzar, E. J., Collins, C., ... & Kalueff, A. V. | ACS chemical neuroscience | 25 September 2018

It’s Tea Time: Interference of Ayahuasca Brew on Discriminative Learning in Zebrafish

Eduardo-da-Silva, P., Lobao-Soares, B., Amarilha, H., Pinheiro-da-Silva, J., Silva, P. F., & Luchiari, A. C. | Frontiers in behavioral neuroscience | 27 August 2018

Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews

dos Santos, R. G., Bouso, J. C., Alcázar-Córcoles, M. Á., & Hallak, J. E. | Expert review of clinical pharmacology | 13 August 2018